Equities

Simcere Pharmaceutical Group Ltd

Simcere Pharmaceutical Group Ltd

Actions
  • Price (USD)0.6922
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jan 31 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade Simcere Pharmaceutical Group Ltd (SMHGF:PKC) traded at 0.6922, 0.00% above its 52-week low of 0.6922, set on Jan 31, 2024.
52-week range
Today
0.6922Jan 31 20240.7585Jan 23 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open--
High0.6922
Low0.6922
Bid--
Offer--
Previous close0.6922
Average volume--
Shares outstanding2.53bn
Free float736.05m
P/E (TTM)--
Market cap17.13bn HKD
EPS (TTM)-0.4528
HKD
Annual div (ADY)0.0225
USD
Annual div yield (ADY)--
Div ex-dateJun 18 2024
Div pay-dateJul 15 2024
Data delayed at least 15 minutes, as of Jan 31 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.